The Fresenius Group, after nearly a century of unremitting efforts, has grown into a large multinational enterprise with businesses in pharmaceuticals, nutrition, medical devices, hospital management and many other healthcare-related industries, employing nearly 60,000 people globally, with branches, subsidiaries, and offices around the world. Fresenius Kabi specializes in the areas of infusion and nutrition with a unique and extensive product line. The company's vision is to be the global expert in infusion, therapeutics and nutrition. In 2003, the company achieved sales of EUR 1.46 billion and employs 11,000 people in more than 30 countries. Fresenius Kabi produces products for infusion and transfusion technology and is the European pioneer in clinical monitoring infusion pumps and transfusion technology. All products are certified according to ISO 9001, EN 46001, IEC 601-1 or EN 60601-1.
Fresenius Kabi is the European healthcare market leader in the field of clinical infusion, especially in the market for syringe pumps, where the company has a market share of about 47%. This large market share is mainly due to the company's representative clinical monitoring products and its ability to provide the clinic with a complete interactive infusion data management system, the Concerto Workstation.
In 1994, Fresenius entered into a joint venture with a Beijing-based pharmaceutical company and established Beijing Fresenius, which was renamed Beijing Fresenius Kabi Pharma Ltd. in 1999 as a result of a merger of foreign shareholdings. Through specialized services and technologically advanced products, Fresenius Kabi Beijing has grown rapidly and created an excellent brand image in the field of anesthesia and ICU therapy, laying a good foundation for the expansion of product lines and business in this field.
In order to better utilize the technological advantages of Fresenius and to provide more and more high-quality and advanced products and services for China's healthcare industry, Fresenius Kabi Asia Pacific Ltd. set up an office in Beijing in March 2004, with the aim of advancing the technological development in the field of transfusion and blood transfusion, and providing a series of equipments and instruments for the management of transfusion and transfusion of blood and blood fluids in the field of critical illnesses and during surgeries. These devices and equipment are based on state-of-the-art German technology and European brand names.